Sort
51,593 grants matching “hepatitis”
MOUSE MODELS OF INSULIN RESISTANCE
$489,503Domenico Accili · Columbia University Health Sciences · R37 · FY2010 · DK
Role of lncRNA Meg3 in obesity-induced endothelial senescence and insulin resistance
$489,484Xinghui Sun · University Of Nebraska Lincoln · R01 · FY2020 · HL
Ventromedial Hypothalamic Regulation of Metabolic Changes Induced by Exercise
$489,407Joel K Elmquist · Ut Southwestern Medical Center · P01 · FY2019 · DK
The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2
$489,396Luke Norton · University Of Texas Hlth Science Center · R01 · FY2023 · DK
Defining successful intrahepatic CD4+ T cell responses against the hepatitis C virus
$489,389Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · AI
Prenatal Phthalates, Placenta Function and Fetal Growth
$489,373Robin Marjorie Whyatt · Columbia University Health Sciences · R01 · FY2007 · ES
Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts
$489,367Jordan S Pober · Yale University · R01 · FY2024 · DK
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION
$489,365Buck Institute For Age Research · R01 · FY2002 · AG
EVALUATION OF ANTIVIRALS FOR HEPATITIS C VIRUS IN CHIMPANZEES
$489,289Robert E Lanford · Texas Biomedical Research Institute · P51 · FY2010 · RR
Clinical Research Network in Non Alcoholic Steatohepati*
$489,230University Of Washington · U01 · FY2004 · DK
Novel regulatory mechanisms control IFNL3 expression during HCV infection
$489,206Ram Savan · University Of Washington · R01 · FY2018 · AI
Heart and Skeletal Muscle Metabolism, Energetics and Function in Barth Syndrome
$489,168William Todd Cade · Washington University · R01 · FY2014 · HL
Hepatocyte Abca1, cholesterol trafficking, and lipid mobilization
$489,166John S Parks · Wake Forest University Health Sciences · R01 · FY2022 · HL
Hepatocyte Abca1, cholesterol trafficking, and lipid mobilization
$489,166John S Parks · Wake Forest University Health Sciences · R01 · FY2021 · HL
Visceral Adiposity, HIV, and HCV: Biologic Mediators of Hepatic Steatosis
$489,161Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2010 · AI
Over-the-Counter PrEP: Acceptability, Feasibility, and Potential Impact of Access without a Prescription (OFFSCRIPT)
$489,120Julia L. Marcus · Harvard Pilgrim Health Care, Inc. · R21 · FY2024 · MH
Comparative Effectiveness of Web-based vs. Traditional Adolescent HIV Prevention
$489,063Lisa A Marsch · National Development And Research Institutes, Inc. · RC1 · FY2009 · DA
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycle
$489,059Stacy Michelle Horner · Duke University · R01 · FY2018 · AI
Cell Cycle Control of Restenosis by apoE
$488,957Richard Assoian · University Of Pennsylvania · P01 · FY2011 · HL
Identification and characterization of cellular factors involved in HCV entry
$488,913Charles M. Rice · Rockefeller University · R01 · FY2012 · AI
Training
$488,879Patricia A Totten · Path · U54 · FY2008 · EB
The mitochondrial aspects of health disparity of hepatocellular carcinoma in Hispanic population
$488,869Yidong Bai · University Of Texas Hlth Science Center · R01 · FY2025 · CA
HIV-sensory neuropathies:risk factors, immunopathology
$488,808Johns Hopkins University · R01 · FY2002 · NS
Mechanisms of Venous Thromboembolism in Cancer
$488,797Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2011 · HL
Cell Cycle Control of Restenosis by apoE
$488,780Richard Assoian · University Of Pennsylvania · P01 · FY2013 · HL